Continuous administration of antisense oligonucleotides to c-fos reduced the development of seizure susceptibility after ethacrynic acid-induced seizure in mice

Neuroscience Letters

Volumn 349, Issue 1, 2003, Pages 21-24

  Suzukawa, Junko ^a   Omori, Kyoko ^a   Yang, Li ^a   Inagaki, Chiyoko ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Antisense phosphorothioated oligodeoxynucleotide; c Fos; Continuous infusion into cerebroventricle; Ethacrynic acid induced seizure; Kainic acid induced seizure; Seizure susceptibility

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ETACRYNIC ACID; KAINIC ACID; MESSENGER RNA; PROTEIN C FOS;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; LATERAL BRAIN VENTRICLE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; STATISTICAL SIGNIFICANCE;

EID: 0142011581     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00674-8     Document Type: Article

References (15)

1. Bing G., Wilson B., Hudson P., Jin L., Feng Z., Zhang W., Bing R., Hong J.S. A single dose of kainic acid elevates the levels of enkephalins and activator protein-1 transcription factors in the hippocampus for up to 1 year. Proc. Natl. Acad. Sci. USA. 94:1997;9422-9427.
2. Cui J.-K., Hsu C.Y., Liu P.K. Suppression of postischemic hippocampal nerve growth factor expression by a c-fos antisense oligodeoxynucleotide. J. Neurosci. 19:1999;1335-1344.
3. Curran T., Miller A.D., Zokas L., Verma I.M. Viral and cellular fos proteins: a comparative analysis. Cell. 36:1984;259-268.
4. Grinkevich L.N., Vasil'ev G.V. Possible molecular-cellular mechanisms of the regulation of gene expression during learning. Neurosci. Behav. Physiol. 30:2000;277-292.
5. Hengerer B., Lindholm D., Heumann R., Rüther U., Wagner E.F., Thoenen H. Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc. Natl. Acad. Sci. USA. 87:1990;3899-3903.
6. Mandelzys A., Gruda M.A., Bravo R., Morgan J.I. Absence of a persistently elevated 37 kDa Fos-related antigen and AP-1-like DNA-binding activity in the brains of kainic acid-treated fosB null mice. J. Neurosci. 17:1997;5407-5415.
7. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroenceph. clin. Neurophysiol. 32:1972;281-294.
8. Rocha L., Kaufman D.L. In vivo administration of c-Fos antisense oligonucleotides accelerates amygdala kindling. Neurosci. Lett. 241:1998;111-114.
9. Rocha L., Ondarza R., Kaufman D.L. Antisense oligonucleotides to c-fos reduce postictal seizure susceptibility following fully kindled seizures in rats. Neurosci. Lett. 268:1999;143-146.
10. Smeyne R.J., Vendrell M., Hayward M., Baker S.J., Miao G.G., Schilling K., Robertson L.M., Curran T., Morgan J.I. Continuous c-fos expression precedes programmed cell death in vivo. Nature. 363:1993;166-169.
11. Sonnenberg J.L., Macgregor-Leon P.F., Curran T., Morgan J.I. Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizure. Neuron. 3:1989;359-365.
12. Sonnenberg J.L., Rauscher F.J. III, Morgan J.I., Curran T. Regulation of proenkephalin by Fos and Jun. Science. 246:1989;1622-1625.
13. Suzukawa J., Omori K., Okugawa G., Fujiseki Y., Heizmann C.W., Inagaki C. Long-lasting c-fos and NGF mRNA expressions and loss of perikaryal parvalbumin immunoreactivity in the development of epileptogenesis after ethacrynic acid-induced seizure. Brain Res. 834:1999;89-102.
14. van der Zee C.E.E.M., Rashid K., Le K., Moore K., Stanisz J., Diamond J., Racine R.J., Fahnestock M. Intraventricular administration of antibodies to nerve growth factor retards kindling and blocks mossy fiber sprouting in adult rats. J. Neurosci. 15:1995;5316-5323.
15. Watanabe Y., Johnson R.S., Butler L.S., Binder D.K., Spiegelman B.M., Papaioannou V.E., McNamara J.O. Null mutation of c-fos impairs structural and functional plasticities in the kindling model of epilepsy. J. Neurosci. 16:1996;3827-3836.